AUS
NZ
UK
CA
USA
IND
Highlights:
- Pro Medicus (ASX:PME) lands a seven-year, A$40 million contract in the US healthcare sector.
- LucidHealth to implement Pro Medicus’ Visage 7 platform for unified diagnostic imaging.
- Contract strengthens the company's foothold in North America's healthcare IT market.
Expanding Presence in the US Radiology Market
Pro Medicus (ASX:PME), a leading provider of medical imaging software, has secured a significant contract with LucidHealth, a prominent radiology service provider in the United States. The seven-year agreement, valued at A$40 million, further reinforces the company's growing influence in the North American healthcare sector.
LucidHealth operates across a network of 140 care sites, with over 300 radiologists offering specialized remote and onsite radiology reading services. With this contract, Pro Medicus will provide a unified diagnostic imaging platform, enhancing the efficiency and effectiveness of radiology operations across the LucidHealth network.
Implementation and Rollout Plans
The deployment of the Visage 7 platform will commence immediately, with a phased go-live expected to begin by the end of the September 2025 quarter or in the December 2025 quarter. This strategic implementation aims to integrate advanced imaging technology seamlessly into LucidHealth’s existing infrastructure, improving diagnostic capabilities and workflow efficiencies.
A key component of this agreement is the adoption of Visage CloudPACS, a cloud-based imaging solution that has been gaining traction in North America. The solution is designed to enhance radiologists’ ability to interpret and manage medical images remotely, streamlining the delivery of high-quality diagnostics.
Executive Insights on the Expansion
Pro Medicus CEO, Dr. Sam Hupert, emphasized the significance of this partnership, stating that LucidHealth's decision to integrate the company's proprietary server-side streaming technology further highlights the competitive advantage of the Visage 7 platform.
Hupert noted that Visage 7 is well-positioned to serve various market segments, including private practices, academic medical centers, integrated delivery networks (IDNs), and outpatient clinics. He also pointed out the growing adoption of Visage CloudPACS among North American clients, underscoring its emergence as a preferred solution in the healthcare IT sector.
Future Growth Outlook
This contract win aligns with the company’s ongoing strategy to expand in the North American healthcare market. With a strong track record of securing high-value agreements, Pro Medicus continues to demonstrate its ability to deliver innovative imaging solutions.
While the stock is currently trading at a premium valuation, the company’s consistent revenue growth and increasing profit margins indicate a promising long-term outlook. As Pro Medicus continues to capture new opportunities, its market positioning remains robust, reinforcing confidence in its expansion strategy.
